Rice, Baylor Developing ‘Glyco-Immune’ Checkpoint Inhibitor

Researchers from Rice University and Baylor College of Medicine are hoping a first-of-its-kind “glyco-immune” checkpoint inhibitor could be the key to stopping bone cancer metastasis for breast cancer survivors.
[Rice University]
Press Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News